Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
Stefano Sacchi, Hagop M. Kantarjian*, Emil J. Freireich, Susan O' Brien, Jorge Cortes, Mary Beth Rios, Steve Kornblau, Francis J. Giles, Charles Koller, James Gajewski, Moshe Talpaz
Dive into the research topics of 'Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia'. Together they form a unique fingerprint.